Verici Dx has made a strategic step with the initiation of the first three clinical trial sites in the US for its validation trial for its lead products, Clarava, Tuteva and the pipeline fibrosis test. Collaborative investigators at these sites are internationally renowned, and their support highlights the global interest in this validation trial and the next-generation sequencing technology. The company is on boarding more sites in the US and EU, and are confident it will meet IPO expectations ....
02 Mar 2021
Initiation of first validation trial sites
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Initiation of first validation trial sites
Verici Dx Plc (VRCI:LON) | 7.2 0 (-6.5%) | Mkt Cap: 17.6m
- Published:
02 Mar 2021 -
Author:
Edward Thomason -
Pages:
3
Verici Dx has made a strategic step with the initiation of the first three clinical trial sites in the US for its validation trial for its lead products, Clarava, Tuteva and the pipeline fibrosis test. Collaborative investigators at these sites are internationally renowned, and their support highlights the global interest in this validation trial and the next-generation sequencing technology. The company is on boarding more sites in the US and EU, and are confident it will meet IPO expectations ....